To challenge Ocrevus, German Merck takes on Aubagio

To challenge Ocrevus, German Merck takes on Aubagio

Submitted by admin on February 23, 2020 - 2:00pm
Source: 
EP Vantage
News Tags: 
Ocrevus
Merck KGaA
Aubagio
evobrutinib
MS
multiple sclerosis
Headline: 
To challenge Ocrevus, German Merck takes on Aubagio
snippet: 

Six months after evobrutinib’s two pivotal multiple sclerosis studies started enrolment, their comparator cohorts are overhauled.

Do Not Allow Advertisers to Use My Personal information